Recent studies in nonobese diabetic mice have implicated the autoimmune destruction of pancreatic islet cells with immunity to a f cell protein cross-reactive to Mycobacterium tuberculosis heat shock protein 65 (hsp 65). Therefore, our studies examined serological immunity to islet cell hsp in humans with insulin-dependent diabetes (IDD). Heat shock of human islet cells in vitro markedly increased the synthesis of proteins of 72,000, 75,000, and 90,000 M,. No autoantibodies reactive to these hsp, nor to the constituently expressed islet cell hsp 65 protein (identified as 60,000 M,) were observed in IDD patients. The islet cell 64,000-M, autoantigen and hsp 65 proteins were physiologically and immunocompetitivly distinct. These experiments do not support the hypothesis that IDD in humans is associated with autoimmunity to islet cell heat shock proteins.
Introduction
The clinical onset ofinsulin-dependent diabetes (IDD)' is characterized by inflammation within the islets (insulitis) and specific loss of the majority of the insulin-producing X cells (1) . In IDD patients, serological autoimmunity is represented by autoantibodies to islet cell cytoplasmic, surface, and insulin autoantigens (2) . In man (3, 4) , the Biobreeding rat (5) , and the nonobese diabetic (NOD) mouse (6) , IDD has also been characterized by autoantibodies directed against an islet # cell protein of 64,000 Mr. However, the role of these autoantibodies in the immunological destruction of f cells remains unclear.
Recent evidence has suggested that a ,3 cell target antigen in NOD mice is a molecule cross-reactive with the 65-kD heat shock protein (hsp 65) of Mycobacterium tuberculosis (7) . In that study, IDD was associated with anti-hsp 65 antibodies, and T cell clones reactive to mycobacterial hsp 65 were able to induce insulitis and hyperglycemia in young NOD mice. Also, the 64,000-M protein was recently proposed by one group to be glutamic acid decarboxylase (8) , while a second group reported the protein to be hsp 65 (9) . Therefore, the goal of our studies was to test human IDD patients for evidence of anti-islet cell hsp autoantibodies including that to the islet cell protein analogous to hsp 65. We also tested for potential antigenic cross-reactivity between the islet cell hsp 65 antigen and the 64,000-M islet cell autoantigen.
Methods
Patient sera and monoclonal antibodies. Sera from two groups of individuals were selected from a previous study (4) for the analyses presented here. There were seven new onset IDD patients (four males/ three females, age 13±11.4 yr) of whom five were autoantibody positive to the 64,000-M, autoantigen. Six nondiabetic controls (three males/three females, age 15±7.3 yr) without any known family history of autoimmune disease were also analyzed. Mouse IgG, MAb IT-13 (suppliers designation WTB 78-A l) (10) reactive to the hsp 65 ofmycobacterium tuberculosis was obtained from the World Health Organization (Immunology of Tuberculosis [IMMTUB] monoclonal antibody bank at the Center for Disease Control, Atlanta, GA).
Human islet cells. Human pancreatic islets were isolated from cadaveric pancreases (I 1) and maintained in vitro as previously described (4) . The islet cells were metabolically labeled with [35Slmethionine (Amersham Corp., Arlington Heights, IL) in vitro (95% air/5% C02). Cells were labeled for 4 h at 370C (4), or labeled for 2 h at 370C followed by incubation at 41 'C for an additional 2 h (12).
Islet cell extractions and immunoprecipitations. Islet cells were extracted as previously described (4) with the following modification. No phase separation was performed after detergent extraction (2 h, 40C) and ultracentrifugation (100,000 g, 45 min 4C). Supernatants containing islet cell protein extracts were collected for total protein analyses or immunoprecipitation. For total protein analysis, equivalent aliquots ofthe islet cell extract were separated by SDS-PAGE according to Laemmli (13) , and subjected to fluororadiography. For immunoprecipitation studies (performed on two occasions), the cell islet lysates were precleared by incubation (2 h, 4'C) with either control or IDD serum (100 ,l), or IT-13 MAb (1I l in 99 ul ofTris buffer [4] 4B (1 h, 4VC), the complexes were then washed five times with 50 mM Tris-HCL (pH 7.4) with 0.1% SDS, 1.0% Triton X-1 14, and 2 mM EDTA, and then washed again one time in double distilled water (4). The protein A sepharose CL-4B was then boiled in Laemmli sample buffer (13) , and samples subjected to SDS-PAGE and fluororadiog- (Fig. 1 lane A) , but its production increased under heat shock conditions ( Fig. 1 lane B) . The hsp 70 family contains a 72-kD hsp that is not obvious in cells grown at 370C, and its induction due to heat shock represents the major translational activity of the stressed cell (13) . The 75,000-M, islet cell protein ( Fig. 1 lane B (Fig. 1 (Fig. 2 lane A) , and the islet cell hsp 65 (60,000 Mr) obtained with the IT-13 MAb (Fig. 2 A, laneC) was observed.
In parallel experiments, extracts from heat shocked islet cells were precleared with identical control sera. Under these conditions, the same five IDD sera immunoprecipitated the 64,000-Mr islet cell autoantigen, however the amount of protein present was noticeably reduced from that obtained by labeling islets at 37°C. None of the six control sera, the two 64,000-M, autoantibody negative IDD sera, nor IT-13 MAb immunoprecipitated the 64,000-Mr protein from this preparation. The IT-13 MAb again immunoprecipitated the band of 60,000 M, (Fig. 2 B, lane C) , and the amount of protein present was not reduced by the heat shock treatment. In contrast, the amount of 64,000-M, protein obtained with IDD sera (Fig. 2 B , lane A) was significantly reduced from that obtained using the same serum sample as used in Fig. 2 A (lane A) . Most interesting, none of the seven IDD or six control sera tested specifically immunoprecipitated any of the islet cell heat shock proteins, including the hsp 65, or the 72,000-, 75,000-, and 90,000-Mr proteins identified in Fig. 1 gen only with IDD sera. As expected, when IT-13 MAb was used as a preclearing reagent of islet cell extracts, immunoprecipitation of hsp 65 using IT-13 MAb was markedly reduced (Fig. 3, lane C) . However, the use of IT-13 MAb as a preclearing reagent had no effect on the quantity of 64,000-M, autoantigen immunoprecipitated by IDD sera (Fig. 3, lane D) .
Whereas this anti-64,000-M, reactivity could be removed when IDD sera was used as a preclearing reagent (Fig. 3 , lane E), preclearance with IDD sera did not effect the ability of MAb IT-13 to immunoprecipitate hsp 65 (Fig. 3 , lane fl.
To confirm the human hsp 65 cross-reactivity with the IT-13 MAb, the antibody was first incubated in the presence of recombinant PI protein (1 pg/ml, 3 h, 40C), the human hsp 65 homologue (14) . After this preadsorption, the IT-13 MAb markedly decreased in its ability to immunoprecipitate islet cell hsp 65, however preincubation of IDD sera with recombinant PI under the same conditions did not effect the ability of the sera to immunoprecipitate 64,000-Mr islet cell autoantigen (data not shown).
Discussion
Exposure ofcells and organisms to heat shock induces a physiological response termed the heat shock response, which is associated with the synthesis of specific hsp ( 17) . The heat shock response represents an immediate, complex, and transient reprogramming of cellular activities, consisting of induction of transcription and synthesis ofhsp, and posttranscriptional inhibition of normal protein synthesis. The heat shock response is not only induced by exposure to elevated temperatures, but also by cellular injury, oxidative injury, viral infections, heavy metals, ethanol, amino acid analogues, and inhibitors ofenergy metabolism. Several groups have suggested a link between the mediators of fever (interleukin 1, interleukin 2, tumor necrosis factor, and interferons) and the heat shock response (16) . Cells deprived of glucose also express a unique family of stress induced proteins (15) .
In these studies, analysis of protein extracts obtained from islet cells subjected to heat shock revealed the expected observation of a decrease in total protein synthesis. However, SDS-PAGE revealed a specific increase in the synthesis of proteins of 72,000, 75,000, and 90,000 M, with heat shock treatment in vitro.
It is possible that heat shock or stress could induce the formation of these three proteins in islet cells in vivo, and thus might present themselves as immunological target antigens in persons developing IDD. However, we observed no evidence for autoimmunity to these proteins as assessed by autoantibody reactivity, since sera from seven new onset IDD patients were unable to immunoprecipitate any of these proteins from islet cells heat shocked in vitro.
Our studies do not support the report by Jones et al. (9) that hsp 65 may represent the 64,000-M autoantigen. Those studies suggested that the 64,000-M protein was induced by stress, and that immunoprecipitation of hsp 65 using monoclonal antibodies to hsp 65 was inhibited by IDD sera. Unfortunately, neither of these findings was described with experimental de- tails nor the control experiments showing competition between the antibodies for these islet cell proteins (18). Our studies, in fact, are in direct opposition in that we observed the 64,000-Mr protein synthesis to be markedly decreased under heat shock conditions. We also established that the monoclonal antibody to hsp 65 reacted to a protein of a different migration in SDS-PAGE than the 64,000-Mr autoantigen, and that no immune competition existed between antibodies to these proteins. As previously mentioned, Elias and colleagues have recently reported the induction and therapy of IDD in NOD mice by hsp 65 (7). However, we observed no autoantibodies in our patients with IDD that reacted to hsp 65 (60,000 Mr). That serological autoimmunity to hsp may underlie the autoimmune pathogenesis ofIDD cannot be confirmed nor supported by these studies ofhumans. Whether a cellular restricted immunity to islet cell hsp exists in humans with IDD is the subject of ongoing investigations.
